was read the article
array:23 [ "pii" => "S2173574311700399" "issn" => "21735743" "doi" => "10.1016/S2173-5743(11)70039-9" "estado" => "S300" "fechaPublicacion" => "2011-05-01" "aid" => "70039" "copyright" => "Sociedad Española de Reumatología and Colegio Mexicano de Reumatología" "copyrightAnyo" => "2011" "documento" => "article" "crossmark" => 0 "subdocumento" => "rev" "cita" => "Reumatol Clin. 2011;7:189-97" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2994 "formatos" => array:3 [ "EPUB" => 63 "HTML" => 2066 "PDF" => 865 ] ] "itemSiguiente" => array:18 [ "pii" => "S2173574311700405" "issn" => "21735743" "doi" => "10.1016/S2173-5743(11)70040-5" "estado" => "S300" "fechaPublicacion" => "2011-05-01" "aid" => "70040" "copyright" => "Sociedad Española de Reumatología and Colegio Mexicano de Reumatología" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "cor" "cita" => "Reumatol Clin. 2011;7:198-9" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2206 "formatos" => array:3 [ "EPUB" => 49 "HTML" => 1255 "PDF" => 902 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case report</span>" "titulo" => "Skin necrosis in a patient with temporal arteritis" "tienePdf" => "en" "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "198" "paginaFinal" => "199" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Necrosis cutánea en paciente con arteritis temporal" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Julio Sánchez Martín" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Julio" "apellidos" => "Sánchez Martín" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574311700405?idApp=UINPBA00004M" "url" => "/21735743/0000000700000003/v1_201305061622/S2173574311700405/v1_201305061622/en/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S2173574311700387" "issn" => "21735743" "doi" => "10.1016/S2173-5743(11)70038-7" "estado" => "S300" "fechaPublicacion" => "2011-05-01" "aid" => "70038" "copyright" => "Sociedad Española de Reumatología and Colegio Mexicano de Reumatología" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Reumatol Clin. 2011;7:179-88" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2417 "formatos" => array:3 [ "EPUB" => 53 "HTML" => 1635 "PDF" => 729 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>" "titulo" => "Consensus statement of the Spanish Society of Rheumatology on the management of biologic therapies in psoriatic arthritis" "tienePdf" => "en" "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "179" "paginaFinal" => "188" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Documento SER de consenso sobre el uso de terapias biológicas en la artritis psoriásica" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Jose Luis Fernández Sueiro, Xavier Juanola Roura, Juan de Dios Cañete Crespillo, Juan Carlos Torre Alonso, Rosario García de Vicuña, Rubén Queiro Silva, Rafael Ariza Ariza, Enrique Batlle Gualda, Estíbaliz Loza Santamaría" "autores" => array:9 [ 0 => array:2 [ "nombre" => "Jose Luis" "apellidos" => "Fernández Sueiro" ] 1 => array:2 [ "nombre" => "Xavier" "apellidos" => "Juanola Roura" ] 2 => array:2 [ "nombre" => "Juan de" "apellidos" => "Dios Cañete Crespillo" ] 3 => array:2 [ "nombre" => "Juan Carlos" "apellidos" => "Torre Alonso" ] 4 => array:2 [ "nombre" => "Rosario García" "apellidos" => "de Vicuña" ] 5 => array:2 [ "nombre" => "Rubén" "apellidos" => "Queiro Silva" ] 6 => array:2 [ "nombre" => "Rafael" "apellidos" => "Ariza Ariza" ] 7 => array:2 [ "nombre" => "Enrique" "apellidos" => "Batlle Gualda" ] 8 => array:2 [ "nombre" => "Estíbaliz" "apellidos" => "Loza Santamaría" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574311700387?idApp=UINPBA00004M" "url" => "/21735743/0000000700000003/v1_201305061622/S2173574311700387/v1_201305061622/en/main.assets" ] "en" => array:15 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review</span>" "titulo" => "Adverse effects of bisphosphonates" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "189" "paginaFinal" => "197" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Luis Arboleya, Mercedes Alperi, Sara Alonso" "autores" => array:3 [ 0 => array:4 [ "nombre" => "Luis" "apellidos" => "Arboleya" "email" => array:1 [ 0 => "arboleya@ser.es" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">¿</span>" "identificador" => "cor0005" ] ] ] 1 => array:2 [ "nombre" => "Mercedes" "apellidos" => "Alperi" ] 2 => array:2 [ "nombre" => "Sara" "apellidos" => "Alonso" ] ] "afiliaciones" => array:1 [ 0 => array:1 [ "entidad" => "Servicio de Reumatología, Hospital Universitario Central de Asturias, Oviedo, Spain" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Efectos adversos de los bisfosfonatos" ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2010-07-05" "fechaAceptado" => "2010-10-05" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec112743" "palabras" => array:3 [ 0 => "Osteoporosis" 1 => "Aminobisphosphonates" 2 => "Adverse effects" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec112744" "palabras" => array:3 [ 0 => "Osteoporosis" 1 => "Bisfosfonatos" 2 => "Efectos adversos" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Aminobisphosphonates are drugs that have been used successfully in the treatment of osteoporosis for more than 20 years. Although main registry studies found a scarcity of relevant adverse events, in recent years and as a result of pharmacovigilance, different complications have been reported, some potentially serious. This has raised questions on the safety of these drugs, especially in high doses, like those used in oncology and long-term treatment, as needed in patients with osteoporosis. In this review, based on the analysis of relevant scientific evidence from clinical trials, case series, cohort studies and databases published to date, we summarize the clinical and epidemiological characteristics of the adverse effects of these drugs.</p>" ] "es" => array:2 [ "titulo" => "Resumen" "resumen" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Los aminobisfosfonatos son fármacos que han sido utilizados con éxito en el tratamiento de la osteoporosis desde hace más de 20 años. Aunque en los estudios principales realizados para obtener la aprobación de su comercialización no se registraron efectos adversos relevantes, en los últimos años, y como resultado de la farmacovigilancia, se ha comunicado de manera irregular una serie de complicaciones, algunas potencialmente graves, que han puesto en duda la seguridad de estos fármacos, sobre todo en dosis elevadas como las que se utilizan en oncología y en tratamientos de larga duración, como los que se emplean en la osteoporosis. En la presente revisión, basada en el análisis de las pruebas científicas más relevantes procedentes de los ensayos clínicos, series de casos, estudios de cohortes y bases de datos publicados hasta el momento, se resumen las características clínicas y epidemiológicas de los efectos adversos de los bisfosfonatos.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:113 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bisfosfonatos" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ …1] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:5 [ "titulo" => "Manual de enfermedades óseas de la Sociedad Española de Reumatología" "paginaInicial" => "319" "paginaFinal" => "330" "edicion" => "2nd ed" "serieFecha" => "2010" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bisphosphonates" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ …1] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:5 [ "titulo" => "Osteoporosis" "paginaInicial" => "1725" "paginaFinal" => "1742" "edicion" => "3rd ed" "serieFecha" => "2008" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Incidence mortality of hip fractures in the United States" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jama.2009.1462" "Revista" => array:6 [ "tituloSerie" => "JAMA" "fecha" => "2009" "volumen" => "302" "paginaInicial" => "1573" "paginaFinal" => "1579" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib4" "etiqueta" => "4." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Declining incidence of hip fractures and the extent of use of anti-osteoporotic therapy in Denmark 1997-2006" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ …2] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Osteoporosis Int" "fecha" => "2010" "volumen" => "21" "paginaInicial" => "373" "paginaFinal" => "380" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib5" "etiqueta" => "5." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Molecular mechanisms of action of bisphosphonates: current status" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Clin Cancer Res" "fecha" => "2006" "volumen" => "12" "paginaInicial" => "6222" "paginaFinal" => "6230" ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib6" "etiqueta" => "6." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Giant osteoclast formation and long-term oral bisphosphonate therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ …3] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa0802633" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2009" "volumen" => "360" "paginaInicial" => "53" "paginaFinal" => "62" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib7" "etiqueta" => "7." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Esophagitis associated with the use of alendronate" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJM199610033351403" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "1996" "volumen" => "335" "paginaInicial" => "1016" "paginaFinal" => "1021" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib8" "etiqueta" => "8." "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Ficha técnica de Fosamax. Available from: <a class="elsevierStyleInterRef" href="http://www.msd.es/content/hcp/productos/ft/ft_fosamax_10_es.pdf">http://www.msd.es/content/hcp/productos/ft/ft_fosamax_10_es.pdf</a>." ] ] ] 8 => array:3 [ "identificador" => "bib9" "etiqueta" => "9." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Gastric and esophagus events before and during treatment of osteoporosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ …5] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00223-009-9323-x" "Revista" => array:6 [ "tituloSerie" => "Calcif Tissue Int" "fecha" => "2010" "volumen" => "86" "paginaInicial" => "110" "paginaFinal" => "115" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib10" "etiqueta" => "10." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Tolerability of different dosing regimens of bisphosphonates for the treatment of osteoporosis and malignant bone disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ …5] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Drug Saf" "fecha" => "2006" "volumen" => "29" "paginaInicial" => "1133" "paginaFinal" => "1152" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib11" "etiqueta" => "11." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparative gastrointestinal safety of weekly oral bisphosphonates" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00198-009-0871-8" "Revista" => array:6 [ "tituloSerie" => "Osteoporos Int" "fecha" => "2009" "volumen" => "20" "paginaInicial" => "1735" "paginaFinal" => "1747" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib12" "etiqueta" => "12." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Reports of esophageal cancer with oral bisphosphonate use" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ …1] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMc0808738" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2009" "volumen" => "360" "paginaInicial" => "89" "paginaFinal" => "90" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib13" "etiqueta" => "13." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "More on reports of esophageal cancer with oral bisphosphonate use" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ …3] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "N Engl J Med" "fecha" => "2009" "volumen" => "360" "paginaInicial" => "1789" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib14" "etiqueta" => "14." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "More on reports of esophageal cancer with oral bisphosphonate use" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ …3] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2009" "volumen" => "360" "paginaInicial" => "1790" "paginaFinal" => "1792" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib15" "etiqueta" => "15." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ …5] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00198-009-0891-4" "Revista" => array:6 [ "tituloSerie" => "Osteoporos Int" "fecha" => "2009" "volumen" => "20" "paginaInicial" => "1989" "paginaFinal" => "1998" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib16" "etiqueta" => "16." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Postmarketing surveillance of uveitis and scleritis with bisphosphonates among a national veteran cohort" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ …2] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/IAE.0b013e31816576ef" "Revista" => array:6 [ "tituloSerie" => "Retina" "fecha" => "2008" "volumen" => "28" "paginaInicial" => "889" "paginaFinal" => "893" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib17" "etiqueta" => "17." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Ophthalmological events in patients receiving risedronate: summary of information gained through follow-up in a prescription-event monitoring study in England" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Drug Safety" "fecha" => "2006" "volumen" => "29" "paginaInicial" => "151" "paginaFinal" => "160" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib18" "etiqueta" => "18." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bilateral acute anterior uveitis after alendronate" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ …3] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Br J Ophthalmol" "fecha" => "2002" "volumen" => "86" "paginaInicial" => "1443" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib19" "etiqueta" => "19." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Scleritis and other ocular side effects associated with pamidronate disodium" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ …3] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Am J Ophthalmol" "fecha" => "2003" "volumen" => "135" "paginaInicial" => "219" "paginaFinal" => "222" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib20" "etiqueta" => "20." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Unilateral anterior uveitis complicating zoledronic acid therapy in breast cancer" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ …3] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/1471-2407-5-156" "Revista" => array:5 [ "tituloSerie" => "BMC Cancer" "fecha" => "2005" "volumen" => "5" "paginaInicial" => "156" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib21" "etiqueta" => "21." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bisphosphonate-associated scleritis: a case report and review" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ …3] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/01.SMJ.0000152753.80490.9F" "Revista" => array:6 [ "tituloSerie" => "South Med J" "fecha" => "2005" "volumen" => "98" "paginaInicial" => "733" "paginaFinal" => "735" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib22" "etiqueta" => "22." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Scleritis complicating zoledronic acid infusion" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3816/CLM.2006.n.053" "Revista" => array:6 [ "tituloSerie" => "Clin Lymphoma Myeloma" "fecha" => "2006" "volumen" => "7" "paginaInicial" => "145" "paginaFinal" => "147" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib23" "etiqueta" => "23." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A case report: zoledronic acid induced uveitis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s12032-007-9006-2" "Revista" => array:6 [ "tituloSerie" => "Med Oncol" "fecha" => "2008" "volumen" => "25" "paginaInicial" => "238" "paginaFinal" => "240" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib24" "etiqueta" => "24." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Nodular scleritis following alendronate therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ …1] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1080/09273940802056281" "Revista" => array:6 [ "tituloSerie" => "Ocul Immunol Inflamm" "fecha" => "2008" "volumen" => "16" "paginaInicial" => "99" "paginaFinal" => "101" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib25" "etiqueta" => "25." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Anterior uveitis complicating zoledronic acid infusion" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ …5] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1080/09273940902916111" "Revista" => array:6 [ "tituloSerie" => "Ocul Immunol Inflamm" "fecha" => "2009" "volumen" => "17" "paginaInicial" => "267" "paginaFinal" => "268" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib26" "etiqueta" => "26." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Ocular toxicity, bisphosphonate and Paget disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ …2] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Med Clin (Barc)" "fecha" => "2009" "volumen" => "133" "paginaInicial" => "198" ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib27" "etiqueta" => "27." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bilateral uveitis secondary to bisphosphonate therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ …3] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000202646" "Revista" => array:6 [ "tituloSerie" => "Ophthalmologica" "fecha" => "2009" "volumen" => "223" "paginaInicial" => "215" "paginaFinal" => "216" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib28" "etiqueta" => "28." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bisphosphonates and iritis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ …1] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "1993" "volumen" => "341" "paginaInicial" => "436" "paginaFinal" => "437" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib29" "etiqueta" => "29." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Orbital inflammatory disease secondary to a single-dose administration of zoledronic acid for treatment of postmenopausal osteoporosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ …2] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00198-009-1048-1" "Revista" => array:6 [ "tituloSerie" => "Osteoporos Int" "fecha" => "2010" "volumen" => "21" "paginaInicial" => "1057" "paginaFinal" => "1058" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib30" "etiqueta" => "30." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Acute retinal pigment epithelial detachment secondary to pamidronate administration" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ …2] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/1078155208097632" "Revista" => array:6 [ "tituloSerie" => "J Oncol Pharm Pract" "fecha" => "2009" "volumen" => "15" "paginaInicial" => "119" "paginaFinal" => "121" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib31" "etiqueta" => "31." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risedronate induced transient ocular myasthenia" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ …3] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Postgrad Med" "fecha" => "2007" "volumen" => "53" "paginaInicial" => "274" "paginaFinal" => "275" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 31 => array:3 [ "identificador" => "bib32" "etiqueta" => "32." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Orbital inflammation and optic neuropathy with zoledronic acid for metastatic prostate cancer" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3129/i09-110" "Revista" => array:6 [ "tituloSerie" => "Can J Ophthalmol" "fecha" => "2009" "volumen" => "44" "paginaInicial" => "467" "paginaFinal" => "468" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 32 => array:3 [ "identificador" => "bib33" "etiqueta" => "33." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Massive proteinuria and acute renal failure after oral bisphosphonate (alendronate) administration in a patient with segmental glomerulosclerosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ …3] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s10157-008-0078-x" "Revista" => array:6 [ "tituloSerie" => "Clin Exp Nephrol" "fecha" => "2009" "volumen" => "13" "paginaInicial" => "85" "paginaFinal" => "88" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 33 => array:3 [ "identificador" => "bib34" "etiqueta" => "34." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/cncr.11701" "Revista" => array:6 [ "tituloSerie" => "Cancer" "fecha" => "2003" "volumen" => "98" "paginaInicial" => "1735" "paginaFinal" => "1744" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 34 => array:3 [ "identificador" => "bib35" "etiqueta" => "35." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Renal failure with the use of zoledronic acid" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ …3] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJM200310233491721" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2003" "volumen" => "349" "paginaInicial" => "1676" "paginaFinal" => "1679" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 35 => array:3 [ "identificador" => "bib36" "etiqueta" => "36." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The issue of renal safety of zoledronic acid from a nephrologist's point of view" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ …1] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1634/theoncologist.10-5-306" "Revista" => array:6 [ "tituloSerie" => "Oncologist" "fecha" => "2005" "volumen" => "10" "paginaInicial" => "306" "paginaFinal" => "308" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 36 => array:3 [ "identificador" => "bib37" "etiqueta" => "37." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bisphosphonate nephrotoxicity" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ …2] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/ki.2008.356" "Revista" => array:6 [ "tituloSerie" => "Kidney Int" "fecha" => "2008" "volumen" => "74" "paginaInicial" => "1385" "paginaFinal" => "1393" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 37 => array:3 [ "identificador" => "bib38" "etiqueta" => "38." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The risk of cumulative renal effects of intravenous bisphosphonates" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ …1] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3816/SCT.2006.n.002" "Revista" => array:6 [ "tituloSerie" => "Support Cancer Ther" "fecha" => "2006" "volumen" => "3" "paginaInicial" => "77" "paginaFinal" => "83" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 38 => array:3 [ "identificador" => "bib39" "etiqueta" => "39." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Measures of renal function BMD, bone loss, and osteoporotic fracture in older adults: the Rancho Bernardo Study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ …3] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Bone Min Res" "fecha" => "2007" "volumen" => "22" "paginaInicial" => "203" "paginaFinal" => "210" ] ] ] ] ] ] 39 => array:3 [ "identificador" => "bib40" "etiqueta" => "40." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risk factors for symtomatic hypocalcemia complicating treatment with zoledronic acid" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ …3] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1445-5994.2007.01580.x" "Revista" => array:6 [ "tituloSerie" => "Intern Med J" "fecha" => "2008" "volumen" => "38" "paginaInicial" => "635" "paginaFinal" => "637" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 40 => array:3 [ "identificador" => "bib41" "etiqueta" => "41." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "High incidence of hypocalcemia and serum creatinine increase in patients with bone metastases treated with zoledronic acid" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1634/theoncologist.2008-0227" "Revista" => array:6 [ "tituloSerie" => "Oncologist" "fecha" => "2009" "volumen" => "14" "paginaInicial" => "548" "paginaFinal" => "556" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 41 => array:3 [ "identificador" => "bib42" "etiqueta" => "42." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hypocalcemia associated with alendronate" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ …3] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Ann Intern Med" "fecha" => "1999" "volumen" => "130" "paginaInicial" => "329" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 42 => array:3 [ "identificador" => "bib43" "etiqueta" => "43." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A review of drug-induced hypocalcemia" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ …3] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00774-009-0119-x" "Revista" => array:6 [ "tituloSerie" => "J Bone Miner Metab" "fecha" => "2009" "volumen" => "27" "paginaInicial" => "635" "paginaFinal" => "642" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 43 => array:3 [ "identificador" => "bib44" "etiqueta" => "44." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bisphosphonate-induced hypocalcemia: report of 3 cases and review of literature" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ …5] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.4158/EP.12.1.48" "Revista" => array:6 [ "tituloSerie" => "Endocr Pract" "fecha" => "2006" "volumen" => "12" "paginaInicial" => "48" "paginaFinal" => "53" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 44 => array:3 [ "identificador" => "bib45" "etiqueta" => "45." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The acute-phase response after bisphosphonate administration" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Calcif Tissue Int" "fecha" => "1987" "volumen" => "41" "paginaInicial" => "326" "paginaFinal" => "331" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 45 => array:3 [ "identificador" => "bib46" "etiqueta" => "46." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Significance and impact of bisphosphonate-induced acute phase responses" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ …2] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/1078155207080806" "Revista" => array:6 [ "tituloSerie" => "J Oncol Pharm Pract" "fecha" => "2007" "volumen" => "13" "paginaInicial" => "223" "paginaFinal" => "229" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 46 => array:3 [ "identificador" => "bib47" "etiqueta" => "47." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The plasticity of gammadelta T Cells: innate immunity, antigen presentation and new immunotherapy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ …2] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/cmi.2008.20" "Revista" => array:6 [ "tituloSerie" => "Cell Mol Immunol" "fecha" => "2008" "volumen" => "5" "paginaInicial" => "161" "paginaFinal" => "170" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 47 => array:3 [ "identificador" => "bib48" "etiqueta" => "48." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Natural and synthetic non-peptide antigens recognized by human gamma delta T cells" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/375155a0" "Revista" => array:6 [ "tituloSerie" => "Nature" "fecha" => "1995" "volumen" => "375" "paginaInicial" => "155" "paginaFinal" => "158" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 48 => array:3 [ "identificador" => "bib49" "etiqueta" => "49." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells" "autores" => array:1 [ 0 => array:2 [ "etal" => false …1 ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Exp Med" "fecha" => "2003" "volumen" => "197" "paginaInicial" => "163" "paginaFinal" => "168" "link" => array:1 [ …1] ] ] ] ] ] ] 49 => array:3 [ "identificador" => "bib50" "etiqueta" => "50." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Immunomodulating role of bisphosphonates on human gamma delta T cells: an intriguing and promising aspect of their antitumour activity" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Expert Opin Ther Targets" "fecha" => "2007" "volumen" => "7" "paginaInicial" => "941" "paginaFinal" => "954" ] ] ] ] ] ] 50 => array:3 [ "identificador" => "bib51" "etiqueta" => "51." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Statins prevent bisphosphonate-induced gamma-delta-T-cell proliferation and activation in vitro" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Bone Miner Res" "fecha" => "2004" "volumen" => "2" "paginaInicial" => "278" "paginaFinal" => "288" ] ] ] ] ] ] 51 => array:3 [ "identificador" => "bib52" "etiqueta" => "52." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The bisphosphonate acute phase response: rapid and copious production of proinflammatory cytokines by peripheral blood gamma/delta T cells in response to aminobisphosphonates is inhibited by statins" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1365-2249.2005.02665.x" "Revista" => array:6 [ "tituloSerie" => "Clin Exp Immunol" "fecha" => "2005" "volumen" => "139" "paginaInicial" => "101" "paginaFinal" => "111" "link" => array:1 [ …1] ] ] ] ] ] ] 52 => array:3 [ "identificador" => "bib53" "etiqueta" => "53." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Atorvastatin may have no effect on acute phase reaction in children following intravenous bisphosphonate infusion" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Bone Min Res" "fecha" => "2009" "volumen" => "24" "paginaInicial" => "334" "paginaFinal" => "337" ] ] ] ] ] ] 53 => array:3 [ "identificador" => "bib54" "etiqueta" => "54." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Serum 25(OH)D levels modulate the Acute Phase Response associated to the first nitrogen containing bisphosphonate infusion" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Bone Miner Res" "fecha" => "2009" "volumen" => "14" "paginaInicial" => "1" "paginaFinal" => "33" "link" => array:1 [ …1] ] ] ] ] ] ] 54 => array:3 [ "identificador" => "bib55" "etiqueta" => "55." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa067312" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2007" "volumen" => "356" "paginaInicial" => "1809" "paginaFinal" => "1822" "link" => array:1 [ …1] ] ] ] ] ] ] 55 => array:3 [ "identificador" => "bib56" "etiqueta" => "56." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Alendronate and atrial fibrillation" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "N End J Med" "fecha" => "2007" "volumen" => "356" "paginaInicial" => "1895" "paginaFinal" => "1896" ] ] ] ] ] ] 56 => array:3 [ "identificador" => "bib57" "etiqueta" => "57." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Use of bisphosphonates among women and risk of atrial fibrillation and flutter: population based case-control study" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/bmj.39507.551644.BE" "Revista" => array:6 [ "tituloSerie" => "BMJ" "fecha" => "2008" "volumen" => "336" "paginaInicial" => "813" "paginaFinal" => "816" "link" => array:1 [ …1] ] ] ] ] ] ] 57 => array:3 [ "identificador" => "bib58" "etiqueta" => "58." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Use of alendronate and risk of incident atrial fibrillation in women" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Arch Int Med" "fecha" => "2008" "volumen" => "168" "paginaInicial" => "826" "paginaFinal" => "831" ] ] ] ] ] ] 58 => array:3 [ "identificador" => "bib59" "etiqueta" => "59." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Zoledronic acid and clinical fractures and mortality after hip fracture" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa074941" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2007" "volumen" => "357" "paginaInicial" => "1799" "paginaFinal" => "1809" "link" => array:1 [ …1] ] ] ] ] ] ] 59 => array:3 [ "identificador" => "bib60" "etiqueta" => "60." "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Available from: <a class="elsevierStyleInterRef" href="http://www.fda.gov./cder/drug/early_comm/bisphosphonates_update_200811.htm">http://www.fda.gov./cder/drug/early_comm/bisphosphonates_update_200811.htm</a>" ] ] ] 60 => array:3 [ "identificador" => "bib61" "etiqueta" => "61." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Alendronate and risedronate: reports of severe bone, joint, and muscle pain" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/archinte.165.3.346-a" "Revista" => array:6 [ "tituloSerie" => "Arch Intern Med." "fecha" => "2005" "volumen" => "165" "paginaInicial" => "346" "paginaFinal" => "347" "link" => array:1 [ …1] ] ] ] ] ] ] 61 => array:3 [ "identificador" => "bib62" "etiqueta" => "62." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Common musculoskeletal adverse effects of oral treatment with once weekly alendronate and risedronate in patients with osteoporosis and ways for their prevention" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Musculoskelet Neuronal Interact" "fecha" => "2007" "volumen" => "7" "paginaInicial" => "144" "paginaFinal" => "148" "link" => array:1 [ …1] ] ] ] ] ] ] 62 => array:3 [ "identificador" => "bib63" "etiqueta" => "63." "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "US Food and Drug Administration. FDA MedWatch Safety Alert Web site. Information for healthcare professionals: bisphosphonates. Available from: <a class="elsevierStyleInterRef" href="http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm101551.htm">http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm101551.htm</a>. Published January 7, 2008." ] ] ] 63 => array:3 [ "identificador" => "bib64" "etiqueta" => "64." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "An observational study of musculoskeletal pain among patients receiving bisphosphonate therapy" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "May Clin Proc" "fecha" => "2010" "volumen" => "85" "paginaInicial" => "341" "paginaFinal" => "348" ] ] ] ] ] ] 64 => array:3 [ "identificador" => "bib65" "etiqueta" => "65." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risedronate-induced arthritis" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/RHU.0b013e3181dfbb15" "Revista" => array:6 [ "tituloSerie" => "J Clin Rheumatol" "fecha" => "2010" "volumen" => "16" "paginaInicial" => "168" "paginaFinal" => "169" "link" => array:1 [ …1] ] ] ] ] ] ] 65 => array:3 [ "identificador" => "bib66" "etiqueta" => "66." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Alendronate-induced synovitis" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Rheumatol" "fecha" => "2008" "volumen" => "35" "paginaInicial" => "537" "paginaFinal" => "538" "link" => array:1 [ …1] ] ] ] ] ] ] 66 => array:3 [ "identificador" => "bib67" "etiqueta" => "67." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Persistent polyarticular synovitis after treatment with alendronate" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Ugeskr Laeger" "fecha" => "2007" "volumen" => "169" "paginaInicial" => "1583" "paginaFinal" => "1584" "link" => array:1 [ …1] ] ] ] ] ] ] 67 => array:3 [ "identificador" => "bib68" "etiqueta" => "68." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Severely suppressed bone turnover: a potential complication of alendronate therapy" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Clin Endocrinol" "fecha" => "2005" "volumen" => "90" "paginaInicial" => "1294" "paginaFinal" => "1301" ] ] ] ] ] ] 68 => array:3 [ "identificador" => "bib69" "etiqueta" => "69." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Renal bone disease: a new conceptual framework for interpretation of bone histomorphometry" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/01.mnh.0000079687.89474.dc" "Revista" => array:6 [ "tituloSerie" => "Curr Opin Nephrol Hypertens" "fecha" => "2003" "volumen" => "12" "paginaInicial" => "387" "paginaFinal" => "408" "link" => array:1 [ …1] ] ] ] ] ] ] 69 => array:3 [ "identificador" => "bib70" "etiqueta" => "70." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Severely suppressed bone turnover and atypical skeletal fragility" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/jc.2007-2803" "Revista" => array:6 [ "tituloSerie" => "J Clin Endocrinol Metab" "fecha" => "2008" "volumen" => "93" "paginaInicial" => "2948" "paginaFinal" => "2952" "link" => array:1 [ …1] ] ] ] ] ] ] 70 => array:3 [ "identificador" => "bib71" "etiqueta" => "71." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Bone Joint Surg (Br)" "fecha" => "2007" "volumen" => "89" "paginaInicial" => "349" "paginaFinal" => "353" ] ] ] ] ] ] 71 => array:3 [ "identificador" => "bib72" "etiqueta" => "72." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Low-energy femoral shaft fractures associated with alendronate use" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/BOT.0b013e318172841c" "Revista" => array:6 [ "tituloSerie" => "J Orthop Trauma" "fecha" => "2008" "volumen" => "22" "paginaInicial" => "346" "paginaFinal" => "350" "link" => array:1 [ …1] ] ] ] ] ] ] 72 => array:3 [ "identificador" => "bib73" "etiqueta" => "73." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bilateral fractures of the femur diaphysis in a patient with rheumatoid arthritis on long-term treatment with alendronate: clues to the mechanism of increased bone fragility" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1359/jbmr.090408" "Revista" => array:6 [ "tituloSerie" => "J Bone Miner Res" "fecha" => "2009" "volumen" => "24" "paginaInicial" => "1736" "paginaFinal" => "1740" "link" => array:1 [ …1] ] ] ] ] ] ] 73 => array:3 [ "identificador" => "bib74" "etiqueta" => "74." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bilateral atypical femoral diaphyseal fractures in a patient treated with alendronate sodium" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1756-185X.2009.01396.x" "Revista" => array:6 [ "tituloSerie" => "Int J Rheum Dis" "fecha" => "2009" "volumen" => "12" "paginaInicial" => "149" "paginaFinal" => "154" "link" => array:1 [ …1] ] ] ] ] ] ] 74 => array:3 [ "identificador" => "bib75" "etiqueta" => "75." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.injury.2007.08.036" "Revista" => array:6 [ "tituloSerie" => "Injury" "fecha" => "2008" "volumen" => "39" "paginaInicial" => "224" "paginaFinal" => "231" "link" => array:1 [ …1] ] ] ] ] ] ] 75 => array:3 [ "identificador" => "bib76" "etiqueta" => "76." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Femoral cortical stress lesions in long-term bisphosphonate therapy: a herald of impending fracture?" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/BOT.0b013e3181b6499b" "Revista" => array:6 [ "tituloSerie" => "J Orthop Trauma" "fecha" => "2010" "volumen" => "24" "paginaInicial" => "75" "paginaFinal" => "81" "link" => array:1 [ …1] ] ] ] ] ] ] 76 => array:3 [ "identificador" => "bib77" "etiqueta" => "77." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa1001086" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2010" "volumen" => "362" "paginaInicial" => "1761" "paginaFinal" => "1771" "link" => array:1 [ …1] ] ] ] ] ] ] 77 => array:3 [ "identificador" => "bib78" "etiqueta" => "78." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pharmacovigilance and reporting oversight in US-FDA fast-track process: bisphosphonates and osteonecrosis of the jaw" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S1470-2045(08)70305-X" "Revista" => array:6 [ "tituloSerie" => "Lancet Oncol" "fecha" => "2008" "volumen" => "9" "paginaInicial" => "1166" "paginaFinal" => "1172" "link" => array:1 [ …1] ] ] ] ] ] ] 78 => array:3 [ "identificador" => "bib79" "etiqueta" => "79." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pamidronate (Aredia) and Zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Oral Maxillofac Surg" "fecha" => "2003" "volumen" => "61" "paginaInicial" => "1238" "paginaFinal" => "1239" "link" => array:1 [ …1] ] ] ] ] ] ] 79 => array:3 [ "identificador" => "bib80" "etiqueta" => "80." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Oral Maxillofac Surg" "fecha" => "2004" "volumen" => "62" "paginaInicial" => "527" "paginaFinal" => "534" "link" => array:1 [ …1] ] ] ] ] ] ] 80 => array:3 [ "identificador" => "bib81" "etiqueta" => "81." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1200/JCO.2005.02.8670" "Revista" => array:6 [ "tituloSerie" => "J Clin Oncol" "fecha" => "2005" "volumen" => "23" "paginaInicial" => "8580" "paginaFinal" => "8587" "link" => array:1 [ …1] ] ] ] ] ] ] 81 => array:3 [ "identificador" => "bib82" "etiqueta" => "82." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Narrative review: bisphosphonates and osteonecrosis of the jaws" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Ann Intern Med" "fecha" => "2006" "volumen" => "144" "paginaInicial" => "753" "paginaFinal" => "761" "link" => array:1 [ …1] ] ] ] ] ] ] 82 => array:3 [ "identificador" => "bib83" "etiqueta" => "83." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Bone Min Res" "fecha" => "2007" "volumen" => "22" "paginaInicial" => "1479" "paginaFinal" => "1491" ] ] ] ] ] ] 83 => array:3 [ "identificador" => "bib84" "etiqueta" => "84." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Adverse effects of bisphosphonates" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00223-010-9364-1" "Revista" => array:6 [ "tituloSerie" => "Calcif Tissue Int" "fecha" => "2010" "volumen" => "86" "paginaInicial" => "421" "paginaFinal" => "435" "link" => array:1 [ …1] ] ] ] ] ] ] 84 => array:3 [ "identificador" => "bib85" "etiqueta" => "85." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bisphosphonate related osteonecrosis of the jaw: a pictorial review" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1148/rg.297095050" "Revista" => array:6 [ "tituloSerie" => "Radiographics" "fecha" => "2009" "volumen" => "29" "paginaInicial" => "1971" "paginaFinal" => "1984" "link" => array:1 [ …1] ] ] ] ] ] ] 85 => array:3 [ "identificador" => "bib86" "etiqueta" => "86." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00784-009-0300-6" "Revista" => array:6 [ "tituloSerie" => "Clin Oral Investig" "fecha" => "2010" "volumen" => "14" "paginaInicial" => "271" "paginaFinal" => "284" "link" => array:1 [ …1] ] ] ] ] ] ] 86 => array:3 [ "identificador" => "bib87" "etiqueta" => "87." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mandibular necrosis in beagle dogs treated with bisphosphonates" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1601-6343.2009.01456.x" "Revista" => array:6 [ "tituloSerie" => "Orthod Craniofac Res" "fecha" => "2009" "volumen" => "12" "paginaInicial" => "221" "paginaFinal" => "228" "link" => array:1 [ …1] ] ] ] ] ] ] 87 => array:3 [ "identificador" => "bib88" "etiqueta" => "88." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Nitrogen-bisphosphonates block retinoblastoma phosphorylation and cell growth by inhibiting the cholesterol biosynthetic pathway in a keratinocyte model for esophageal irritation" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Mol Pharmacol" "fecha" => "2001" "volumen" => "59" "paginaInicial" => "193" "paginaFinal" => "202" "link" => array:1 [ …1] ] ] ] ] ] ] 88 => array:3 [ "identificador" => "bib89" "etiqueta" => "89." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Higher incidence of osteonecrosis of the jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1080/07357900802208608" "Revista" => array:6 [ "tituloSerie" => "Cancer Invest" "fecha" => "2009" "volumen" => "27" "paginaInicial" => "221" "paginaFinal" => "226" "link" => array:1 [ …1] ] ] ] ] ] ] 89 => array:3 [ "identificador" => "bib90" "etiqueta" => "90." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bisphosphonates cause Osteonecrosis of the jaw-like disease in mice" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2353/ajpath.2010.090592" "Revista" => array:6 [ "tituloSerie" => "Am J Pathol" "fecha" => "2010" "volumen" => "177" "paginaInicial" => "280" "paginaFinal" => "290" "link" => array:1 [ …1] ] ] ] ] ] ] 90 => array:3 [ "identificador" => "bib91" "etiqueta" => "91." "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Nota informativa, 2009/10., Nota informativa 2009/10. Recomendaciones para la prevención de la osteonecrosis del maxilar asociada al tratamiento con bisfosfonatos [accessed 2010 May 4]. Agencia Española de Medicamentos y Productos Sanitarios. Available from: <a class="elsevierStyleInterRef" href="http://www.aemps.es/actividad/alertas/usoHumano/seguridad/NI_2009-10_bisfosfonatos.htm">http://www.aemps.es/actividad/alertas/usoHumano/seguridad/NI_2009-10_bisfosfonatos.htm</a>" ] ] ] 91 => array:3 [ "identificador" => "bib92" "etiqueta" => "92." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Oral bisphosphonateinduced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.joms.2007.08.003" "Revista" => array:6 [ "tituloSerie" => "J Oral Maxillofac Surg" "fecha" => "2007" "volumen" => "65" "paginaInicial" => "2397" "paginaFinal" => "2410" "link" => array:1 [ …1] ] ] ] ] ] ] 92 => array:3 [ "identificador" => "bib93" "etiqueta" => "93." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.joms.2009.02.004" "Revista" => array:6 [ "tituloSerie" => "J Oral Maxillofac Surg" "fecha" => "2009" "volumen" => "67" "paginaInicial" => "1167" "paginaFinal" => "1173" "link" => array:1 [ …1] ] ] ] ] ] ] 93 => array:3 [ "identificador" => "bib94" "etiqueta" => "94." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Assessing the clinical utility of serum CTX in postmenopausal osteoporosis and its use in predicting risk of osteonecrosis of the jaw" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1359/jbmr.090203" "Revista" => array:6 [ "tituloSerie" => "J Bone Miner Res" "fecha" => "2009" "volumen" => "24" "paginaInicial" => "561" "paginaFinal" => "574" "link" => array:1 [ …1] ] ] ] ] ] ] 94 => array:3 [ "identificador" => "bib95" "etiqueta" => "95." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1359/jbmr.080205" "Revista" => array:6 [ "tituloSerie" => "J Bone Miner Res" "fecha" => "2008" "volumen" => "23" "paginaInicial" => "826" "paginaFinal" => "836" "link" => array:1 [ …1] ] ] ] ] ] ] 95 => array:3 [ "identificador" => "bib96" "etiqueta" => "96." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.oraloncology.2007.11.012" "Revista" => array:6 [ "tituloSerie" => "Oral Oncol" "fecha" => "2008" "volumen" => "44" "paginaInicial" => "857" "paginaFinal" => "869" "link" => array:1 [ …1] ] ] ] ] ] ] 96 => array:3 [ "identificador" => "bib97" "etiqueta" => "97." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1200/JCO.2009.21.9584" "Revista" => array:6 [ "tituloSerie" => "J Clin Oncol" "fecha" => "2009" "volumen" => "27" "paginaInicial" => "5356" "paginaFinal" => "5362" "link" => array:1 [ …1] ] ] ] ] ] ] 97 => array:3 [ "identificador" => "bib98" "etiqueta" => "98." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Incidence of bisphosphonate-associated osteonecrosis of the jaws in breast cancer patients" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/cncr.24119" "Revista" => array:6 [ "tituloSerie" => "Cancer" "fecha" => "2009" "volumen" => "115" "paginaInicial" => "1631" "paginaFinal" => "1637" "link" => array:1 [ …1] ] ] ] ] ] ] 98 => array:3 [ "identificador" => "bib99" "etiqueta" => "99." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Higher incidence of Osteonecrosis of the Jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Cancer Invest" "fecha" => "2009" "volumen" => "2" "paginaInicial" => "221" "paginaFinal" => "226" ] ] ] ] ] ] 99 => array:3 [ "identificador" => "bib100" "etiqueta" => "100." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s10549-010-0866-3" "Revista" => array:6 [ "tituloSerie" => "Breast Cancer Res Treat" "fecha" => "2010" "volumen" => "122" "paginaInicial" => "181" "paginaFinal" => "188" "link" => array:1 [ …1] ] ] ] ] ] ] 100 => array:3 [ "identificador" => "bib101" "etiqueta" => "101." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Disease specific risk for an osteonecrosis of the jaw under bisphosphonate therapy" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00432-009-0662-9" "Revista" => array:6 [ "tituloSerie" => "J Cancer Res Clin Oncol" "fecha" => "2010" "volumen" => "136" "paginaInicial" => "363" "paginaFinal" => "370" "link" => array:1 [ …1] ] ] ] ] ] ] 101 => array:3 [ "identificador" => "bib102" "etiqueta" => "102." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.joms.2009.03.050" "Revista" => array:6 [ "tituloSerie" => "J Oral Maxillofac Surg" "fecha" => "2010" "volumen" => "68" "paginaInicial" => "243" "paginaFinal" => "253" "link" => array:1 [ …1] ] ] ] ] ] ] 102 => array:3 [ "identificador" => "bib103" "etiqueta" => "103." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.joms.2006.10.061" "Revista" => array:6 [ "tituloSerie" => "J Oral Maxillofac Surg" "fecha" => "2007" "volumen" => "65" "paginaInicial" => "415" "paginaFinal" => "423" "link" => array:1 [ …1] ] ] ] ] ] ] 103 => array:3 [ "identificador" => "bib104" "etiqueta" => "104." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw: an institutional inquiry" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Am Dent Assoc" "fecha" => "2009" "volumen" => "140" "paginaInicial" => "61" "paginaFinal" => "66" "link" => array:1 [ …1] ] ] ] ] ] ] 104 => array:3 [ "identificador" => "bib105" "etiqueta" => "105." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/(SICI)1096-9926(199908)60:2<68::AID-TERA10>3.0.CO;2-H" "Revista" => array:6 [ "tituloSerie" => "Teratology" "fecha" => "1999" "volumen" => "60" "paginaInicial" => "68" "paginaFinal" => "73" "link" => array:1 [ …1] ] ] ] ] ] ] 105 => array:3 [ "identificador" => "bib106" "etiqueta" => "106." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "No effects of bisphosphonates on the human fetus" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Birth Defects Res" "fecha" => "2003" "volumen" => "67" "paginaInicial" => "203" "paginaFinal" => "204" ] ] ] ] ] ] 106 => array:3 [ "identificador" => "bib107" "etiqueta" => "107." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Intravenous pamidronate for treatment of reflex sympathetic dystrophy during breast feeding" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1359/jbmr.2000.15.10.2052" "Revista" => array:6 [ "tituloSerie" => "J Bone Miner Res" "fecha" => "2000" "volumen" => "15" "paginaInicial" => "2052" "paginaFinal" => "2055" "link" => array:1 [ …1] ] ] ] ] ] ] 107 => array:3 [ "identificador" => "bib108" "etiqueta" => "108." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Anti-inflammatory and immunosuppresive drugs and reproduction" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/ar1957" "Revista" => array:6 [ "tituloSerie" => "Arthritis Res Ther" "fecha" => "2006" "volumen" => "8" "paginaInicial" => "209" "paginaFinal" => "228" "link" => array:1 [ …1] ] ] ] ] ] ] 108 => array:3 [ "identificador" => "bib109" "etiqueta" => "109." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment of osteoporosis: recognizing and managing cutaneous adverse reactions and drug-induced hypersensitivity" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00198-009-1097-5" "Revista" => array:6 [ "tituloSerie" => "Osteoporos Int" "fecha" => "2010" "volumen" => "21" "paginaInicial" => "723" "paginaFinal" => "732" "link" => array:1 [ …1] ] ] ] ] ] ] 109 => array:3 [ "identificador" => "bib110" "etiqueta" => "110." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hepatotoxicity induced by alendronate therapy" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00198-007-0323-2" "Revista" => array:6 [ "tituloSerie" => "Osteoporos Int" "fecha" => "2007" "volumen" => "18" "paginaInicial" => "829" "paginaFinal" => "831" "link" => array:1 [ …1] ] ] ] ] ] ] 110 => array:3 [ "identificador" => "bib111" "etiqueta" => "111." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Liver damage due to alendronate" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJM200008033430512" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2000" "volumen" => "343" "paginaInicial" => "365" "paginaFinal" => "366" "link" => array:1 [ …1] ] ] ] ] ] ] 111 => array:3 [ "identificador" => "bib112" "etiqueta" => "112." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prescription event monitoring study on 13,164 patients prescribed risedronate in primary care in England" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00198-005-1986-1" "Revista" => array:6 [ "tituloSerie" => "Osteoporos Int" "fecha" => "2005" "volumen" => "16" "paginaInicial" => "1989" "paginaFinal" => "1998" "link" => array:1 [ …1] ] ] ] ] ] ] 112 => array:3 [ "identificador" => "bib113" "etiqueta" => "113." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pharmacovigilance study of alendronate in England" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00198-003-1399-y" "Revista" => array:6 [ "tituloSerie" => "Osteoporos Int" "fecha" => "2003" "volumen" => "14" "paginaInicial" => "507" "paginaFinal" => "514" "link" => array:1 [ …1] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/21735743/0000000700000003/v1_201305061622/S2173574311700399/v1_201305061622/en/main.assets" "Apartado" => array:4 [ "identificador" => "8381" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Review" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/21735743/0000000700000003/v1_201305061622/S2173574311700399/v1_201305061622/en/main.pdf?idApp=UINPBA00004M&text.app=https://reumatologiaclinica.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574311700399?idApp=UINPBA00004M" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 9 | 18 | 27 |
2024 October | 30 | 59 | 89 |
2024 September | 37 | 47 | 84 |
2024 August | 48 | 59 | 107 |
2024 July | 35 | 47 | 82 |
2024 June | 53 | 65 | 118 |
2024 May | 39 | 56 | 95 |
2024 April | 37 | 40 | 77 |
2024 March | 28 | 41 | 69 |
2024 February | 29 | 35 | 64 |
2024 January | 23 | 30 | 53 |
2023 December | 14 | 32 | 46 |
2023 November | 26 | 34 | 60 |
2023 October | 28 | 45 | 73 |
2023 September | 24 | 50 | 74 |
2023 August | 24 | 21 | 45 |
2023 July | 11 | 23 | 34 |
2023 June | 53 | 34 | 87 |
2023 May | 29 | 24 | 53 |
2023 April | 17 | 25 | 42 |
2023 March | 33 | 40 | 73 |
2023 February | 18 | 31 | 49 |
2023 January | 22 | 30 | 52 |
2022 December | 37 | 41 | 78 |
2022 November | 42 | 31 | 73 |
2022 October | 29 | 20 | 49 |
2022 September | 34 | 47 | 81 |
2022 August | 28 | 48 | 76 |
2022 July | 22 | 61 | 83 |
2022 June | 35 | 48 | 83 |
2022 May | 40 | 57 | 97 |
2022 April | 66 | 66 | 132 |
2022 March | 41 | 49 | 90 |
2022 February | 28 | 44 | 72 |
2022 January | 23 | 28 | 51 |
2021 December | 22 | 56 | 78 |
2021 November | 35 | 70 | 105 |
2021 October | 85 | 74 | 159 |
2021 September | 64 | 54 | 118 |
2021 August | 60 | 50 | 110 |
2021 July | 21 | 34 | 55 |
2021 June | 28 | 52 | 80 |
2021 May | 38 | 41 | 79 |
2021 April | 154 | 113 | 267 |
2021 March | 93 | 34 | 127 |
2021 February | 55 | 29 | 84 |
2021 January | 34 | 20 | 54 |
2020 December | 35 | 31 | 66 |
2020 November | 33 | 25 | 58 |
2020 October | 17 | 16 | 33 |
2020 September | 19 | 21 | 40 |
2020 August | 17 | 25 | 42 |
2020 July | 19 | 16 | 35 |
2020 June | 32 | 24 | 56 |
2020 May | 23 | 19 | 42 |
2020 April | 24 | 18 | 42 |
2020 March | 17 | 11 | 28 |
2020 January | 4 | 0 | 4 |
2019 September | 4 | 0 | 4 |
2019 June | 2 | 0 | 2 |
2019 March | 2 | 0 | 2 |
2019 January | 1 | 0 | 1 |
2018 May | 7 | 1 | 8 |
2018 April | 29 | 15 | 44 |
2018 March | 27 | 21 | 48 |
2018 February | 17 | 10 | 27 |
2018 January | 11 | 8 | 19 |
2017 December | 20 | 10 | 30 |
2017 November | 20 | 8 | 28 |
2017 October | 29 | 5 | 34 |
2017 September | 14 | 10 | 24 |
2017 August | 19 | 8 | 27 |
2017 July | 18 | 15 | 33 |
2017 June | 33 | 26 | 59 |
2017 May | 38 | 11 | 49 |
2017 April | 26 | 9 | 35 |
2017 March | 23 | 29 | 52 |
2017 February | 18 | 4 | 22 |
2017 January | 15 | 5 | 20 |
2016 December | 53 | 16 | 69 |
2016 November | 47 | 6 | 53 |
2016 October | 70 | 12 | 82 |
2016 September | 49 | 1 | 50 |
2016 August | 23 | 1 | 24 |
2016 July | 12 | 4 | 16 |
2016 June | 0 | 3 | 3 |
2016 May | 0 | 3 | 3 |
2016 March | 4 | 3 | 7 |
2016 February | 6 | 0 | 6 |
2015 December | 5 | 0 | 5 |
2015 November | 1 | 0 | 1 |
2015 September | 2 | 14 | 16 |
2015 August | 3 | 0 | 3 |
2015 July | 20 | 9 | 29 |
2015 June | 38 | 11 | 49 |
2015 May | 47 | 25 | 72 |
2015 April | 35 | 16 | 51 |
2015 March | 48 | 12 | 60 |
2015 February | 50 | 17 | 67 |
2015 January | 41 | 35 | 76 |
2014 December | 27 | 22 | 49 |
2014 November | 37 | 21 | 58 |
2014 October | 30 | 17 | 47 |
2014 September | 30 | 18 | 48 |
2014 August | 31 | 26 | 57 |
2014 July | 32 | 21 | 53 |
2014 June | 53 | 13 | 66 |
2014 May | 41 | 22 | 63 |
2014 April | 43 | 14 | 57 |
2014 March | 57 | 18 | 75 |
2014 February | 50 | 18 | 68 |
2014 January | 44 | 19 | 63 |
2013 December | 38 | 9 | 47 |
2013 November | 52 | 35 | 87 |
2013 October | 64 | 23 | 87 |
2013 September | 47 | 15 | 62 |
2013 August | 47 | 18 | 65 |
2013 July | 42 | 14 | 56 |
2013 June | 28 | 13 | 41 |
2013 May | 23 | 14 | 37 |
2013 April | 39 | 16 | 55 |
2013 March | 26 | 25 | 51 |
2013 February | 22 | 19 | 41 |
2013 January | 50 | 12 | 62 |
2012 December | 60 | 16 | 76 |
2012 November | 37 | 11 | 48 |
2012 October | 10 | 5 | 15 |
2012 September | 25 | 8 | 33 |
2012 July | 1 | 0 | 1 |
2012 June | 3 | 0 | 3 |
2012 May | 2 | 0 | 2 |
2012 April | 4 | 0 | 4 |
2012 February | 2 | 0 | 2 |
2012 January | 3 | 0 | 3 |
2011 December | 4 | 0 | 4 |
2011 November | 2 | 0 | 2 |
2011 October | 4 | 0 | 4 |
2011 September | 6 | 0 | 6 |
2011 August | 4 | 0 | 4 |
2011 July | 2 | 0 | 2 |
2011 June | 11 | 0 | 11 |
2011 May | 2 | 0 | 2 |